FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to new derivative 5'-O-(4-phenylbutanoyl)-N4-hydroxycytidine, as well as to a method for production thereof and use of the compound for inhibiting replication of coronavirus SARS-CoV-2.
EFFECT: novel compound having high activity against coronavirus SARS-CoV-2 is obtained.
6 cl, 3 ex, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
5'-O-(4-CHLOROPHENOXYACETYL)-N4-HYDROXYCYTIDINE AND USE THEREOF | 2023 |
|
RU2817609C1 |
METHOD FOR OBTAINING 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE | 2022 |
|
RU2791916C1 |
5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE AND ITS APPLICATION | 2022 |
|
RU2791523C1 |
USE OF 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE TO INHIBIT INFLUENZA VIRUS REPLICATION IN VITRO AND IN VIVO | 2022 |
|
RU2791806C1 |
URACIL DERIVATIVES WITH ANTIVIRAL ACTIVITY AGAINST SARS-COV-2 | 2021 |
|
RU2769828C1 |
APPLICATION OF AN OXYGEN-CONTAINING DERIVATIVE OF 6-HALOQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2, AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2780245C1 |
mRNA-BASED VECTOR FOR INCREASED TARGET PROTEIN PRODUCTION IN MAMMALIAN CELLS (VARIANTS) | 2022 |
|
RU2792231C1 |
APPLICATION OF A TRICYCLIC SULPHUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2 | 2021 |
|
RU2780247C1 |
METHOD OF OBTAINING DODECAPEPTIDE AND TRIPEPTIDE FOR ITS REALISATION | 2007 |
|
RU2340626C1 |
METHOD FOR PREPARING A THIO DERIVATIVE OF PYRROLIDINE-2,5-DIONE WITH A QUINAZOLINE FRAGMENT | 2021 |
|
RU2807057C2 |
Authors
Dates
2024-04-11—Published
2023-10-18—Filed